scispace - formally typeset
H

Hyunsuk Shim

Researcher at Emory University

Publications -  140
Citations -  8124

Hyunsuk Shim is an academic researcher from Emory University. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 42, co-authored 129 publications receiving 7291 citations. Previous affiliations of Hyunsuk Shim include Johns Hopkins University School of Medicine & Georgia State University.

Papers
More filters
Journal ArticleDOI

c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth

TL;DR: It is suggested that an increased LDH-A level is required for the growth of a transformed spheroid cell mass, which has a hypoxic internal microenvironment and is necessary for c-Myc-mediated transformation.
Journal ArticleDOI

Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc

TL;DR: Findings suggest that overexpression of the c-Myc oncoprotein deregulates glycolysis through the activation of several components of the glucose metabolic pathway.
Journal Article

Silencing of CXCR4 blocks breast cancer metastasis

TL;DR: It is shown that direct injection of a pool of naked small interfering RNA (siRNA) duplexes can prevent tumorigenesis in an animal model, suggesting a novel preventive and therapeutic strategy for cancer management.
Journal ArticleDOI

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.

TL;DR: The role of a synthetic antagonist 14-mer peptide (TN14003) in inhibiting metastasis of breast cancer by inhibiting migration is investigated and may prove useful as a diagnostic tool to identify CXCR4 receptor-positive tumor cells in culture and tumors in paraffin-embedded clinical samples.
Journal ArticleDOI

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

TL;DR: Findings demonstrate for the first time the involvement of miRNAs in multidrug resistance mediated by MRP-1 and suggest that miR-326 may be an efficient agent for preventing and reversing MDR in tumor cells.